$ 5.48
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of BSGM is 10.0 and suggests 82% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
